Bayer AG (BAYRY)
12.21
-0.03
(-0.25%)
USD |
OTCM |
Oct 12, 16:00
Bayer Price to Book Value : 1.419 for Oct. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.419 |
| October 09, 2026 | 1.422 |
| October 08, 2026 | 1.402 |
| October 07, 2026 | 1.424 |
| October 06, 2026 | 1.443 |
| October 05, 2026 | 1.440 |
| October 02, 2026 | 1.469 |
| October 01, 2026 | 1.479 |
| September 30, 2026 | 1.568 |
| September 29, 2026 | 1.614 |
| September 28, 2026 | 1.68 |
| September 25, 2026 | 1.664 |
| September 24, 2026 | 1.640 |
| September 23, 2026 | 1.636 |
| September 22, 2026 | 1.648 |
| September 21, 2026 | 1.631 |
| September 18, 2026 | 1.599 |
| September 17, 2026 | 1.642 |
| September 16, 2026 | 1.632 |
| September 15, 2026 | 1.631 |
| September 14, 2026 | 1.658 |
| September 11, 2026 | 1.621 |
| September 10, 2026 | 1.635 |
| September 09, 2026 | 1.663 |
| September 08, 2026 | 1.664 |
| Date | Value |
|---|---|
| September 04, 2026 | 1.649 |
| September 03, 2026 | 1.667 |
| September 02, 2026 | 1.652 |
| September 01, 2026 | 1.640 |
| August 31, 2026 | 1.656 |
| August 28, 2026 | 1.629 |
| August 27, 2026 | 1.639 |
| August 26, 2026 | 1.656 |
| August 25, 2026 | 1.666 |
| August 24, 2026 | 1.640 |
| August 21, 2026 | 1.634 |
| August 20, 2026 | 1.640 |
| August 19, 2026 | 1.670 |
| August 18, 2026 | 1.640 |
| August 17, 2026 | 1.608 |
| August 14, 2026 | 1.608 |
| August 13, 2026 | 1.608 |
| August 12, 2026 | 1.616 |
| August 11, 2026 | 1.658 |
| August 10, 2026 | 1.650 |
| August 07, 2026 | 1.678 |
| August 06, 2026 | 1.664 |
| August 05, 2026 | 1.654 |
| August 04, 2026 | 1.624 |
| August 03, 2026 | 1.577 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 1.953 |
| Breakthrough Chemistry, Inc. | 1.527 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.219 |
| Carl Zeiss Meditec AG | 3.282 |
Price to Book Value Related Metrics
| PS Ratio | 0.9066 |
| Price to Free Cash Flow | 64.95 |
| Price | 12.21 |
| Earnings Yield | -4.19% |
| Market Cap | 47.98B |
| Operating PE Ratio | 6.563 |
| Normalized PE Ratio | 24.72 |